Alzheimer disease trials, also abroad
815 open Alzheimer disease trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
| Country | Open trials |
|---|---|
| United States | 359 |
| China | 134 |
| France | 85 |
| Italy | 60 |
| Spain | 58 |
| All other countries |
The same trial often runs in several countries
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3) has 1 site in Greece and runs in 31 countries. If a site near you is full, another one may still take people.
See Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3) in all 31 countries